Merck Animal Health Donates $250,000 to Iowa State University for New Veterinary Diagnostic Laboratory
Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, New Jersey, USA (NYSE:MRK), announced a $250,000 donation to Iowa State University (ISU) to support the new Veterinary Diagnostic Laboratory.
“We’re grateful for Merck Animal Health’s support in assisting to build this state-of-the-art veterinary diagnostic lab which will allow Iowa State University to continue to develop innovative solutions for generations to come in a wide range of diagnostic services,” said Dan Grooms, D.V.M., Ph.D., the Dr. Stephen G. Juelsgaard Dean of Veterinary Medicine. “The diagnostic lab has long played a key role in advancing animal and public health while ensuring the world’s food supply is safe and plentiful.”
Construction on phase one of the facility is underway with a planned opening in 2023. Merck Animal Health’s donation will directly support the new “Science on Display” area which enhances educational opportunities for professional and graduate students, scientists, diagnosticians and practitioners.
Providing funding for the Veterinary Diagnostic Laboratory is one of several initiatives and collaborations between Merck Animal Health and ISU. Recently, Merck Animal Health and ISU announced a four-year strategic alliance that will bring together industry and university talent as part of a unique public-private partnership to address complex needs and expedite the delivery of animal health solutions to the marketplace. Merck Animal Health also has supported veterinary internships and scholarships as well as research and development projects at the university.
“We are excited to continue our long-standing partnership with ISU and be a part of this new state-of-the-art facility,” said Brent Meyer, D.V.M., M.S., beef technical services, Merck Animal Health. “Our investment is part of our commitment to the veterinary profession and in advancing the future of animal health.”
About Merck Animal Health
For over 130 years, Merck Animal Health, known as MSD outside the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Merck Animal Health, a division of Merck & Co., Inc., Kenilworth, New Jersey, USA, is the global animal health business unit of Merck. Through its commitment to The Science of Healthier Animals®, Merck Animal Health offers veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of connected technology that includes identification, traceability and monitoring products. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. For more information, visit www.merck-animal-health.com.
About Iowa State University
Iowa State University, located in Ames, Iowa, and founded in 1858, is a renowned research university with a comprehensive land-grant mission of education, innovation, extension and outreach that benefits Iowans and the world. Innovate at Iowa State reflects the university’s national leadership for providing innovative and entrepreneurial opportunities for students of diverse backgrounds. Iowa State enrolls nearly 31,000 students and employs more than 6,000 faculty and staff.
The Iowa State College of Veterinary Medicine is the nation’s first public veterinary college and is widely renowned as one of the best. The Veterinary Diagnostic Laboratory is a national leader in protecting animal and human health. The Nanovaccine Institute, a consortium of 79 researchers at 23 universities, research institutes, national laboratories and companies coordinated by Iowa State, is dedicated to revolutionizing the prevention and treatment of disease through nanovaccines and nanotherapeutics.
